An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia.

Autor: Colombo, Giorgio L., Caruggi, Mauro, Di Matteo, Sergio, Rossi, Alessandro
Zdroj: Neuropsychiatric Disease & Treatment; 2008, Vol. 4 Issue 5, p967-976, 10p
Databáze: Complementary Index